Goodo.
But really all a tad vague, it seems to me: no indication of timing, no detail of milestones or of the relationship with St. Vincent’s Institute of Medical Research (which to be fair is likely as solid a partner EchoIQ could wish for).
Still counting down - now 76 sleeps - to 5 August for news from the US Food and Drug Administration (FDA) on EchoSolv™ AS.
Ann: Echo IQ Commences New Heart Failure Clinical Study Using AI, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $138.7M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 20.5¢ | $321.5K | 1.516M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 212563 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 400412 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |